Steven Boyd, 10% Owner at ReShape Lifesciences Inc. (RSLS), bought 100 shares at $3.75 ($375) on 2020-09-16, disclosed to the SEC on 2020-09-16.
Open-market purchase of $375 RSLS by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Negative factors outweigh the positive ones.
| Filing → |
| AVTX | BUY | 2022-01-14 | $451K | — | Filing → |
| CERC | BUY | 2021-08-18 | $194K | — | Filing → |
| EYEG | SELL | 2021-07-29 | $27.9M | — | Filing → |